# Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT

> **NCT03963024** · PHASE1 · TERMINATED · sponsor: **IRCCS San Raffaele** · enrollment: 9 (actual)

## Conditions studied

- Irradiated Bone Marrow
- Transplant-Related Hematologic Malignancy
- Leukemia, Acute
- Multiple Myeloma
- Graft Vs Host Disease

## Interventions

- **DRUG:** Conditioning treatment "Treosulfan-TMI"
- **PROCEDURE:** SCT
- **DRUG:** GvHD prophylaxis

## Key facts

- **NCT ID:** NCT03963024
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02-12
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-01-31
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** low rate of enrolment
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963024, "Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT03963024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*